Decoding kinase-adverse event associations for small molecule kinase inhibitors

Small molecule kinase inhibitors (SMKIs) are being approved at a fast pace under expedited programs for anticancer treatment. In this study, we construct a multi-domain dataset from a total of 4638 patients in the registrational trials of 16 FDA-approved SMKIs and employ a machine-learning model to...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Xiajing, Hu, Meng, Liu, Jinzhong, Kim, Geoffrey, Xu, James, McKee, Amy, Palmby, Todd, de Claro, R. Angelo, Zhao, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329312/
https://www.ncbi.nlm.nih.gov/pubmed/35896580
http://dx.doi.org/10.1038/s41467-022-32033-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329312/
https://www.ncbi.nlm.nih.gov/pubmed/35896580
http://dx.doi.org/10.1038/s41467-022-32033-5

Ejemplares similares